A single-center experience of COVID-19 infection in patients with primary immunodeficiency

Background: Reported outcomes in patients with primary immunodeficiency (PID) infected by coronavirus disease 2019 (COVID-19) have been variable owing to a combination of viral strain heterogeneity, differences in patient populations and health systems, and local availability of vaccination and spec...

Full description

Bibliographic Details
Main Authors: Jessie J. Zhou, BMed, MD, Celina Jin, BMedSci, MBBS(Hons), DPhil, FRACP, FRCPA, Zhi Xiang Leang, MBBS, Josh Chatelier, MBBS, BSc(Hons), FRACP, Jack Godsell, MBBS(Hons), BMedSc(Hons), FRACP, Sylvia Tsang, MNSc, Jo A. Douglass, BMedSc(Hons), MBBS (Hons), MD, FRACP, Michelle K. Yong, MBBS, FRACP, MPH, PhD, Monica Slavin, MBBS, FRACP, MD, FAAHMS, FECMM, Vanessa L. Bryant, Bsc(Hons), Bsc, PhD, Charlotte A. Slade, MBBS, BA, BSc, FRACP, FRCPA, PhD, Samantha Chan, MBBS, BMedSci, FRACP, MPH
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829324000377